Skip to content

Determination of ED50 and ED95 of Oseltamivir by Probit Regression in Elderly Patients Undergoing Painless Gastroscopy with Compound Cyclopofol

Determination of ED50 and ED95 of Oseltamivir by Probit Regression in Elderly Patients Undergoing Painless Gastroscopy with Compound Cyclopofol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120519
Enrollment
Unknown
Registered
2026-03-16
Start date
2026-03-16
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastrointestinal endoscopy

Interventions

O1:Normal saline + cyclopofol
O2:5 µ g/kg of oxelidin + cyclopofol
O3:10 µ g/kg of oxelidin + cyclopofol
O4:15 µ g/kg of oxelidin + cyclopofol
O5:20 µ g/kg of oxelidin + cyclopofol
O6:25 µ g/kg of oxelidin + cyclopofol
O7:30 µ g/kg of oxelidin + cyclopofol

Sponsors

Hainan Provincial People's Hospital (Affiliated Hospital of Hainan Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. 105 elderly patients scheduled for painless gastroscopy; 2. ASA grades I to III; 3. Age > 65 years old; 4. BMI 15 - 28 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Have a history of highly reactive airway diseases, have acute upper respiratory tract infections, have a high risk of aspiration, have esophageal stenosis or cardiosphincter obstruction, have acute upper gastrointestinal bleeding, have hearing impairment; 2. Have severe lesions in important organs such as heart, liver, lungs and kidneys, as well as water and electrolyte disorders, have a history of mental illness, have a long-term history of taking psychotropic and sedative-hypnotic drugs, have sleep apnea syndrome, and have a history of drug allergies; 3. Have participated in other clinical trials as subjects within the past 3 months and have refused to undergo this clinical research experiment.

Design outcomes

Primary

MeasureTime frame
Intolerance response indicators (choking cough reflex, swallowing reflex, retching reflex, limb movement response);

Secondary

MeasureTime frame
Bispectral index monitoring;Gastroscopy examination time ;Heart rate;Postoperative recovery time;Mean arterial pressure;

Countries

China

Contacts

Public ContactNa Li

Hainan Provincial People's Hospital (Affiliated Hospital of Hainan Medical University)

33293996@qq.com+86 186 0898 8600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026